Multiple Myeloma: International Myeloma Foundation : •about myeloma    : get the correct diagnosis : Smoldering Myeloma (high risk)

get the correct diagnosis

back

Smoldering Myeloma (high risk)

	07.18.11
Be the first to comment Name Email Address URL Remember personal info? Comments (You may use HTML tags for style)	print share \| related articles Insights into Smolde... What is Smoldering M... ASH 2011: Dr. Mateos... High-Risk Smoldering...

Insights into Smoldering (Asymptomatic) Multiple Myeloma

What is Smoldering Myeloma?

ASH 2011: Dr. Mateos - Smoldering Multiple Myeloma (SMM) At High-Risk of Progression to Symptomatic Disease: A Phase III, Randomized, Multicenter Trial Based On Lenalidomide-Dexamethasone (Len-Dex) As Induction Therapy Followed by Maintenance Therapy with Len Alone Vs No Treatment

High-Risk Smoldering Myeloma Addressed by Group 1 during Second Annual International Myeloma Working Group Summit

You might also be interested in:

Insights into Smoldering (Asymptomatic) Multiple Myeloma

An ASCO Connection Current Controversies in Oncology article featuring Dr. Kyle of the Mayo Clinic.

What is Smoldering Myeloma?

Dr. Ola Landgren
National Cancer Institute
Bethesda, Maryland

María-Victoria Mateos, MD, PhD
Hospital Clinico Universitario
Salamanca, Spain

High-Risk Smoldering Myeloma Addressed by Group 1 during Second Annual International Myeloma Working Group Summit

How to maximize benefits of early treatment for patients with high-risk smoldering myeloma, yet avoid unnecessary treatment and toxicities.

Be the first to comment